Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2018Journal of Translational MedicineOpen Access

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

View Full Paper
Ask AI
Bookmark
Share

Authors

QSQipeng SunJinan UniversityZHZhengyu HuangTongji UniversityFHFei HanChinese Academy of Medical Sciences & Peking Union Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sun et al. (2018) studied this question.

synapsesocial.com/papers/6a9957c23ea09d5cf8f5a3cchttps://doi.org/10.1186/s12967-018-1422-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intra Renal Arterial Injection of Autologous Mesenchymal Stem Cells in an Ovine Model in the Postischemic Kidney2007 · 77 citations
  2. 2OXYGEN PERSUFFLATION INCREASES PANCREATIC ATP LEVELS AND VIABLE ISLET YIELD FOLLOWING 24 HOURS PRESERVATION COMPARED WITH THE TWO-LAYER METHOD (TLM)2010 · 64 citations
  3. 3WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation12010 · 165 citations
  4. 4Timing and Dose Regimens of Marrow Mesenchymal Stem Cell Transplantation Affect the Outcomes and Neuroinflammatory Response After Ischemic Stroke2014 · 90 citations
  5. 5Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study2013 · 367 citations